InvestorsHub Logo

Jonjones325

11/22/22 5:43 PM

#384749 RE: rx7171 #384748

It’s the only one that is late breaking. We know the results of the others already.

falconer66a

11/22/22 6:05 PM

#384750 RE: rx7171 #384748

Big Pharma People KNOW, Are Watching

Success with Sigma 1 agonist will be the end of their amyloid focused careers and they know it.

The generally perceived consensus on this message board (wrong) is that in all the world the only people who really know and follow Anavex’s unique sigma-1 receptor activating molecules are the people who read and post messages here. Few others know or care or understand.

Entirely wrong. The science insiders at every Big Pharma closely follow everything that we post here. After all, if the Anavex sigma-1 activation mechanism proves successful, “amyloid focused careers” are truly in danger. Millions upon millions of pharmaceutical drug development dollars are at risk. Entire careers and programs and laboratories are in jeopardy. Would these people decline to examine the Anavex science reports that both the company and we posters display here? Of course not. They keep up to date on everything Anavex posts. They even read and consider the science postings we put up on this message board.

Of course, the general investment communities, both retail equity buyers, and institutional investment firms are, presently, ignorant of Anavex science. Few of them are reading or comprehending what appears on this message board. But after 1 December, readership on this board will explode. Will be fun to watch....